A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
1855 patients around the world
Available in Brazil
A phase 3, multicenter, national, randomized, double-blind, double-dummy, parallel-group,
active-drug and placebo-controlled, superiority clinical trial. Individuals of both sexes
aged ≥18 years and ≤60 years, overweight (BMI ≥ 27kg/m2) in the presence of comorbidities
(dyslipidemia, systemic arterial hypertension [SAH], pre-diabetes and/or sleep apnea) or
obese (BMI ≥ 30kg/m2 and < 45kg/m2).
